Cariprazine as a useful treatment for patients with schizophrenia and antipsychotic-induced extrapyramidal symptoms: a case report and literature review
Introduction The discovery of second-generation antipsychotics represented an authentic breakthrough for the management of psychotic disorders. Nevertheless, they still don’t adequately manage some aspects of these disorders, such as negative symptoms (NS), cognitive impairment, or extra-pyramidal...
Main Authors: | C. Llach, L. Ilzarbe, M. Sagué-Vilavella, N. Arbelo, R. Catalan, F. Gutierrez |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822020478/type/journal_article |
Similar Items
-
Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
by: Aleksandr M. Reznik, et al.
Published: (2020-10-01) -
Cariprazine: Patients with Treatment-Resistant Schizophrenia
by: Aubel T
Published: (2021-07-01) -
The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia
by: I. Laszlovszky, et al.
Published: (2021-04-01) -
Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
by: Montes JM, et al.
Published: (2021-02-01) -
A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
by: Panneer Selvan, et al.
Published: (2024-04-01)